Adrenal Castleman’s disease

被引:0
作者
Karsten Müssig
Marius Horger
Manfred Wehrmann
机构
[1] University Hospital of Tübingen,Division of Endocrinology, Metabolism and Pathobiochemistry, Department of Internal Medicine
[2] University Hospital of Tübingen,Department of Diagnostic Radiology
[3] University Hospital of Tübingen,Department of General Pathology
来源
Annals of Hematology | 2007年 / 86卷
关键词
Adrenal Gland; Heterotopic Ossification; Irbesartan; Urapidil; Retroperitoneal Lymph Node;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:63 / 65
页数:2
相关论文
共 63 条
  • [1] Keller AR(1972)Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations Cancer 29 670-683
  • [2] Hochholzer L(1999)The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature Cancer 85 706-717
  • [3] Castleman B(1991)Castleman disease of the adrenal gland: MR imaging features AJR Am J Roentgenol 157 781-783
  • [4] Bowne WB(2002)Castleman’s disease masquerading as an adrenal tumor J Urol 168 2524-356
  • [5] Lewis JJ(2005)Castleman’s disease in the left upper retroperitoneal space mimicking an adrenal neoplasm: report of a case and literature review Jpn J Clin Oncol 35 353-2930
  • [6] Filippa DA(1991)Interleukin-6 gene expression in Castleman’s disease Blood 78 2923-137
  • [7] Niesvizky R(1998)The pathophysiologic roles of interleukin-6 in human disease Ann Intern Med 128 127-1694
  • [8] Brooks AD(1993)Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans J Clin Endocrinol Metab 77 1690-606
  • [9] Burt ME(2005)Interleukin-6: an osteotropic factor influencing bone formation? Bone 37 601-32
  • [10] Brennan MF(2002)Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells Exp Cell Res 280 24-574